• Modern Retina
  • Ophthalmology TimesOphthalmology Times
  • Ophthalmology Times EuropeOphthalmology Times Europe
  • Optometry TimesOptometry Times
Modern Retina
Modern Retina
Spotlight
iCare COMPASS Automated Perimeter
Clinical
View MoreAMDDiabetic Macular EdemaDiabetic RetinopathyImagingOphthalmologyRetinal SurgeryUveitisWet AMD
News
Blogs
Media
Case-Based Roundtable Series
Expert Interviews
Eyeviews
Insights
Medical World News
Podcasts
Rapid Readouts
Viewpoints
Conference
Conference Coverage
Conference Listing
Residents
Residents
Research Scholar Honoree Program
Resident Writer
Publications
Modern Retina Digital Edition
Supplements And Featured Publications
Resources
CME/CE
Sponsored Resources
partners
Subscribe
eNewsletter
  • Advertise
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Modern Retina. All rights reserved.

Spotlight
  • iCare COMPASS Automated Perimeter
ClinicalSee All >
  • AMD
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • Imaging
  • Ophthalmology
  • Retinal Surgery
  • Uveitis
  • Wet AMD
  • Advertise
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.

Advancement in the management of wet AMD

Caroline R Baumal, MD, Thomas Albini, MD, Aleksandra Rachitskaya, MD, and Michael Singer, MD, discuss a number of topics pertaining to wet age-related macular degeneration (wet AMD) including the diagnosis and clinical manifestations, treatment options, and the impact of the COVID-19 pandemic on management of wet AMD.

EP. 1: Introduction and definition of macular degeneration

November 19th 2020

EP. 2: Identifying a typical patient with Wet AMD

November 19th 2020

EP. 3: Clinical trials vs real-world data on wet AMD

November 19th 2020

EP. 4: Anti-VEGF agents for treatment of wet AMD

November 19th 2020

EP. 5: Personal experience with anti-VEGF agents for wet AMD

November 19th 2020

EP. 6: Reasons for switching between agents for wet AMD

November 19th 2020

EP. 7: Safety concerns with anti-VEGF agents for wet AMD

November 19th 2020

EP. 8: Role of biosimilars in management of wet AMD

November 19th 2020

EP. 9: Compounds and home monitoring device in development for wet AMD

November 19th 2020

EP. 10: The impact of COVID-19 on the management of wet AMD

November 19th 2020